Pyrrolocarbazoles as Checkpoint 1 Kinase Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 6, 2008-08 ,pp. : 577-597

Bentham Science Publishers

Access to resources Recommend Favorite

Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells

By    

Biomedical Reports, Vol. 4, Iss. 1, 2016-01 ,pp. : 83-86

Science Publishers

Access to resources Recommend Favorite

Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia

By  

Current Cancer Therapy Reviews, Vol. 9, Iss. 3, 2013-08 ,pp. : 181-219

Bentham Science Publishers

Access to resources Recommend Favorite

FLT1 kinase is a mediator of radioresistance and survival in head and neck squamous cell carcinoma

By Van Limbergen Evert Jan   Zabrocki Piotr   Porcu Michaël   Hauben Esther   Cools Jan   Nuyts Sandra  

Acta Oncologica, Vol. 53, Iss. 5, 2014-05 ,pp. : 637-645

Informa Healthcare

Access to resources Recommend Favorite

Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability

By Shin H.-J.   Baek K.-H.   Jeon A.-H.   Park M.-T.   Lee S.-J.   Kang C.-M.   Lee H.-S.   Yoo S.-H.   Chung D.-H.   Sung Y.-C.   McKeon F.   Lee C.-W.  

Cancer Cell, Vol. 4, Iss. 6, 2003-12 ,pp. : 483-497

Elsevier

Access to resources Recommend Favorite